Suscribirse

Exposure to diesel exhaust particles increases susceptibility to invasive pneumococcal disease - 06/04/20

Doi : 10.1016/j.jaci.2019.11.039 
Rebecca K. Shears, PhD a, Laura C. Jacques, PhD a, , Georgia Naylor, MBiol a, , Lisa Miyashita, PhD b, Shadia Khandaker, PhD a, Filipa Lebre, PhD c, Ed C. Lavelle, PhD c, Jonathan Grigg, MD FRCPCH b, Neil French, PhD FRCP a, Daniel R. Neill, PhD a, d, Aras Kadioglu, PhD a,
a Bacterial Pathogenesis and Immunity Group, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom 
b Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, United Kingdom 
c Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland 
d Microbial Evolution, Genomics and Adaptation Group, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom 

Corresponding author: Aras Kadioglu, PhD, Department of Clinical Infection Microbiology & Immunology, Institute of Infection & Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby St, Liverpool, United Kingdom, L69 7BE.Department of Clinical Infection Microbiology & ImmunologyInstitute of Infection & Global HealthUniversity of LiverpoolThe Ronald Ross Building8 West Derby StLiverpoolL69 7BEUnited Kingdom

Abstract

Background

The World Health Organization estimates that air pollution is responsible for 7 million deaths per annum, with 7% of these attributable to pneumonia. Many of these fatalities have been linked to exposure to high levels of airborne particulates, such as diesel exhaust particles (DEPs).

Objectives

We sought to determine whether exposure to DEPs could promote the progression of asymptomatic nasopharyngeal carriage of Streptococcus pneumoniae to invasive pneumococcal disease.

Methods

We used mouse models and in vitro assays to provide a mechanistic understanding of the link between DEP exposure and pneumococcal disease risk, and we confirmed our findings by using induced sputum macrophages isolated from healthy human volunteers.

Results

We demonstrate that inhaled exposure to DEPs disrupts asymptomatic nasopharyngeal carriage of S pneumoniae in mice, leading to dissemination to lungs and blood. Pneumococci are transported from the nasopharynx to the lungs following exposure to DEPs, leading to increased proinflammatory cytokine production, reduced phagocytic function of alveolar macrophages, and consequently, increased pneumococcal loads within the lungs and translocation into blood. These findings were confirmed by using DEP-exposed induced sputum macrophages isolated from healthy volunteers, demonstrating that impaired innate immune mechanisms following DEP exposure are also at play in humans.

Conclusion

Lung inhaled DEPs increase susceptibility to pneumococcal disease by leading to loss of immunological control of pneumococcal colonisation, increased inflammation, tissue damage, and systemic bacterial dissemination.

El texto completo de este artículo está disponible en PDF.

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Key words : Streptococcus pneumoniae, pneumococcus, pneumonia, pneumococcal disease, particulates, pollution

Abbreviations used : BAL, BMDM, CFU, DEP, FITC, FSC, GFP, IPD, OPKA, UK


Esquema


 Supported by a UK Medical Research Council Programme Grant (MR/P011284/1) awarded to A.K. D.R.N. was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (204457/Z/16/Z).
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


Crown Copyright © 2019  Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 145 - N° 4

P. 1272 - avril 2020 Regresar al número
Artículo precedente Artículo precedente
  • Treatment with rapamycin can restore regulatory T-cell function in IPEX patients
  • Laura Passerini, Federica Barzaghi, Rosalia Curto, Claudia Sartirana, Graziano Barera, Francesca Tucci, Luca Albarello, Alberto Mariani, Pier Alberto Testoni, Elena Bazzigaluppi, Emanuele Bosi, Vito Lampasona, Olaf Neth, Daniele Zama, Manfred Hoenig, Ansgar Schulz, Markus G. Seidel, Ivana Rabbone, Sven Olek, Maria G. Roncarolo, Maria P. Cicalese, Alessandro Aiuti, Rosa Bacchetta
| Artículo siguiente Artículo siguiente
  • Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients
  • Jacob W. Glickman, Celina Dubin, Joseph Han, Dante Dahabreh, Sandra Garcet, James G. Krueger, Ana B. Pavel, Emma Guttman-Yassky

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.